Market Overview   The global Type 1 Alpha-1 Antitrypsin Deficiency Treatment Market was valued at US$ YY billion in 2023 and is projected to reach US$ YY billion by 2031, registering a CAGR of YY% throughout the forecast period 2024–2031. The Type 1 Alpha-1 Antitrypsin Deficiency Treatment Market is expanding rapidly, fueled by risks of lung diseases from insufficient AAT protein...